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ABSTRACT 
Objective: To develop and evaluate floating type gastro-retentive dosage form, appropriate for controlled release of repaglinide (RG) having a 
narrow therapeutic window.  
Methods: Repaglinide loaded microspheres (MS) using biological macromolecule ethylcellulose (EC) was prepared by a solvent diffusion-evaporation 
technique using polyvinyl alcohol (PVA) emulsifier. Compatibility of drug and polymer was studied by Fourier-transform infrared spectroscopy (FTIR). 
During formulation, various process optimisation parameters studied were stirring speed, the concentration of drug, polymer and emulsifier. 
Characterization and in vitro evaluation was performed. In vivo antidiabetic activity was performed on alloxan induced diabetic rats followed by 
histopathological screening.  
Results: The average particle size was in the range of 174-243 µm. Yield, entrapment and buoyancy of microspheres were 68.4-79.8, 58.6-73.1 and 
71.8-84.1% respectively. 65.1% release of drug from optimised formulation was obtained which follows first-order kinetics (r2 = 0.989). Optimised 
formulation treated group shows significant (p<0.01) decrease in glucose level of blood as compared to pure drug treated group during the later 
hours of study with satisfactory results of histology.  
Conclusion: The investigation revealed the promising potential of gastro retentive microspheres for delivering RG for the treatment of non-insulin 
dependent diabetes mellitus (NIDDM). 
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Oral dosage form capable of having prolonged retention in the 
stomach, to deliver the drug for an extended period of time has been 
receiving much attention nowadays [1]. Gastric residence time (GRT) 
is one of the important factors which affect the bioavailability of the 
drug in dosage forms [2]. Variable and short gastric emptying time 
leads to incomplete drug release from delivery system in the stomach 
and upper part of small intestine, leading to decrease the efficacy of 
administered dose [3]. Bioavailability of drug can be sufficiently 
increased by prolonging GRT through gastro-retentive dosage form 
like floating drug delivery system (FDDS) [4]. Floating dosage forms 
remains buoyant over gastric and intestinal fluid due to having a lesser 
density than aqueous medium. Both single and multiple systems of 
floating dosage forms have been developed in previous years. Multiple 
unit dosage forms can be a good alternative than single unit form, as 
they shows less inter and intra variability’s in drug absorption and 
also lowers the probability of dose dumping [5].  
Various types of gastrointestinal target dosage forms including floating 
intragastric system [6, 7], the high-density system [8], mucoadhesive 
system adhering to the gastric mucosal surface to extend GRT [9], the 
magnetic system [10] and swellable systems have been developed [11]. 
For controlled release of drug EC is generally used because of its non-
biodegradable, biocompatible nature and low cost. In the recent 
literature, several authors have reported EC microspheres for 
encapsulation of various drugs such as rabeprazole sodium [12], 
dextromethorphan hydro bromide [13], cimetidine [14] etc. for some 
or the other reasons. However, no microspheres of RG were prepared 
using EC have been reported. These MS were prepared by evaporation 
of organic solvents to get hollow spheres to float over gastric fluid.  
RG is an oral hypoglycemic agent of meglitinide class which induces 
rapid onset and short lasting insulin release. Because of short lasting 
action (1 h) it may have a lower risk of serious hypoglycemia [15]. 
.Microspheres encapsulated with the anti-diabetic drug, increase the 
effectiveness and release of drug in control manner from polymeric 
membrane thereby, and maintain its concentration for a longer 
duration. Due to short lasting action, fast clearance, enzymatic stability 
and absorption throughout git, RG is selected as a suitable target for 
developing gastro retentive dosage form. The aim of the study is to 
increase the bioavailability and reduce the side effects (skeletal 
muscles pain, headache and git effects) of repaglinide. Moreover, the 
success of control release of drug in diabetic condition and non-toxic 
nature of RG can be achieved by performing antidiabetic activity 
followed by histopathology during the study. 
MATERIALSAND METHODS 
Materials 
RG was procured as gift sample from Torrent Pharmaceuticals, 
Ahmedabad, India and EC were purchased from Himedia chemicals, 
India. Analytical grade ethanol, dichloromethane were purchased 
from SD fine chemicals Mumbai, India. 
Compatibility study 
Compatibility of drug and polymer was studied by obtaining IR 
spectra’s of RG, EC and mixture of both by FTIR spectrophotometer 
(Shimadzu 8400, Japan). 
Preparation of microspheres 
MS of RG were prepared by the solvent diffusion-evaporation 
technique with slight modification [16]. RG and EC were mixed in 
1:1 mixture of ethanol and dichloromethane at various ratios. 0.1% 
of PEG was added as a surfactant and the slurry was slowly 
introduced into 80 ml of 0.46% w/v of polyvinyl alcohol as an 
emulsifier. The system was stirred using propeller agitator for about 
1 h for evaporation of organic phase. The prepared MS were washed 
3-4 times with distilled water, dried for 1 h at room temperature and 
subsequently stored in a desiccator over fused calcium chloride. 
Characterization 
Micromeretics and surface morphology 
Floating MS were characterised for particle size, bulk density, tapped 
density and angle of repose. Particle size was measured using an optical 
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microscopy and mean particle size was calculated with calibrated ocular 
micrometre. Tapping method is utilised for estimation of tapped density. 
The tapping was carried out in a 10 ml measuring cylinder on a hard 
surface with a rate of 100 taps per minute until no further change in the 
volume was noted. To study the flow characteristics, the angle of repose 
was measured by fixed funnel method.  
The surface morphology (SEM) was measured by scanning electron 
microscope (Jeol JSM-1600, Tokyo, Japan). 
In vitro evaluation of floating ability 
About 50 mg of MS were placed in 100 ml of simulated gastric fluid 
(pH 1.2) containing Tween 20 (0.02 w/v %) and stirred with a 
magnetic stirrer at 100 rpm. After 12 h, the floating and settled 
micro particles were separated, dried and weighed. The buoyancy 
was calculated by using the formula given as under:  
Buoyancy (%) = Wb/(Wb+WS) X 100 
Where Wb and Ws are the weights of the floating and settled 
microparticles, respectively. 
% Yield and drug entrapment efficiency 
The % yield was calculated by using the formula as follows:  
% Yield = (Total weight of microspheres floating/Total weight of 
drug and polymer) X 100 
The floating MS equivalent to 50 mg of RG has weighed accurately, 
crushed and was placed in 10 ml of ethanol for 12 h. The solution 
was then filtered through Whatman filter paper no. 44 and the 
absorbance were measured at 247 nm using UV spectrophotometer. 
The percent drug entrapped was calculated using the formula:  
% Drug entrapment = (Calculated drug content/Theoretical drug 
content) X 100 
In vitro drug release and kinetic studies 
Floating microspheres of optimised batch equivalent to 16 mg drug 
were placed in 0.1N HCl (1.2 pH) containing Tween 20 (0.02 w/v %) 
in paddle type six-station dissolution test apparatus (Veego, VDA-
6DR, USP Std) at a rotation speed of 100 rpm. Sink condition was 
maintained throughout the study; 1 ml of the sample was withdrawn 
after every h and analysed spectrophotometrically at 247 nm.  
Release mechanism was studied by fitting release data to different 
mathematical models such as Zero order (% cumulative drug release 
vs. Time), First order (log % drug release vs. Time), Higuchi model 
(% cumulative drug release vs. square root of time) and Peppas 
exponential equation (log % drug release vs. log time). All curve 
fitting, calculations and plotting were done by Microsoft excel solver 
and regression coefficient (r2) values were calculated. 
Antidiabetic activity and histopathology 
The antidiabetic study performed was approved by Institutional 
Animal Ethics Committee, Shri Ram Institute of Technology Pharmacy, 
Jabalpur, Madhya Pradesh (Protocol No: SRITP/IAEC/2014/01). 
Animals were housed individually in polypropylene cages and 
maintained under standard conditions (12 h light and 12 h dark cycle; 
25-30 °C). Healthy male albino rats of average body weight about 150-
200 g were selected for in vivo antidiabetic activity. Five rats in four 
groups were housed properly in cages and maintained with standard 
conditions. Group A and B contain normal and diabetic control rats 
(induced with single iv injection of 120 mg/kg of alloxan) provided 
with drinking water. Group C and D contain diabetic rats with pure 
repaglinide (4 mg/kg body weight) and optimised formulation (E2) of 
MS equivalent to the dose of drug respectively using the intragastric 
tube. Animals were provided with water ad libitum during the course of 
study. Blood samples were collected from the tail vein of rats and 
checked for plasma glucose level using Accu-chek active glucose strips in 
Accu-check active test meter. Blood samples were withdrawn after every 
30 min up to 4 h and then the sample was taken on the 6thand 8thh for 
glucose estimation. Treatment was continued for 15 consecutive days.  
On the fifteenth day animals were sacrificed and liver, pancreas, 
heart and kidney of rats were isolated individually. These collected 
organs were excised quickly and fixed in 10% formalin for the 
histopathological test. Tissues were fixed in paraffin blocks, sliced 
and placed onto glass slides. After staining slides were observed and 
photos were taken using topical microscope [17]. 
Statistical analysis 
Data are given as mean±standard error of the mean. Data were 
analysed with ANOVA where the control group was compared with 
rest group. Significance was set at *p<0.05, **p<0.01, ***p<0.001. 
RESULTS AND DISCUSSION 
Compatibility studies 
FTIR spectra were recorded for RG, EC and physical mixture of both 
(fig. 1). Spectra of RG shows peaks at 3308 cm-1 (NH stretching), 
2947 cm-1 (CH stretching), 1220 cm-1 (CH3) and 1685 cm-1(C=O). 
Spectra of EC shows the sharp band at 2929 cm-1 associated with a 
CH stretching vibration and a broader band centred at about 3481 
cm-1, corresponds to OH stretching vibration. Spectra of mixture of 
drug and polymer shows characteristic peaks of drug at 3308 cm-
1(NH stretching), 1687 cm-1(C=O), 1218 cm-1 (CH3) and 2934 cm-
1(CH stretching) however no major shift and broadening in the 
absorption bands of drug was observed therefore no interaction 
between the two was concluded. The characteristic peaks of the 
drug appeared at an almost same wavelength, even when mixed 
with EC which indicate that no chemical incompatibility results 




Fig. 1: Infrared spectra: A) Repaglinide, B) Ethylcellulose and C) 
Mixture of repaglinide and ethylcellulose 
 
Formation of microspheres 
Preformulation trials were undertaken for certain proportions of 
drug and polymer by varying stirring speed, the concentration of 
drug and emulsifier for determination of qualitative and quantitative 
characteristics of floating MS. Composition of different MS prepared 
were shown in table 1. Prepared formulation shows desirable high 
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content, yield, buoyancy, release and hence found to be suitable for 
the development of control release system of the drug. The floating 
MS were prepared by solvent diffusion evaporation technique. A 
suspension of drug and EC in solvent having equal ratios of ethanol 
and dichloromethane was prepared forming an organic phase and 
was poured into an aqueous phase containing polyvinyl alcohol. As 
the organic phase is added to external aqueous phase, it gets 
partitioned into the two phases and results in complete precipitation 
of polymer around the drug particle.  
Continuous stirring of the aqueous phase helps in proper evaporation of 
solvent and formation of microspheres [14]. To observe the effect of 
agitation speed on various parameters of MS, the formulations were 
prepared by varying stirring speed (600, 900 and 1200 rpm). 
 
Table 1: Composition of ethyl cellulose microspheres 
Batch code Amount of EC (mg) Concentration of emulsifying agent (%) Stirring  rate (rpm) Amount of drug (mg) 
E1 10 0.46 900 10 
E2 20 0.46 900 10 
E3 30 0.46 900 10 
E4 20 0.46 600 10 
E5 20 0.46 1200 10 
E6 20 0.66 900 10 
E7 20 0.86 900 10 
E8 20 0.46 900 20 
E9 20 0.46 900 30 
 
Micromeretics properties 
It has been observed that the mean particle size of the MS 
significantly increases (187±7.2-234±10.2) with an increase in 
EC concentration. At higher polymer concentration the viscosity 
of the medium increases which results in increased interfacial 
tension. Shearing efficiency is also decreased at higher 
viscosities, which results in the formation of larger particles 
[18]. As the stirring rate was increased from 600 to 1200 rpm 
particle size decreases. The bulk and tapped density were found 
in the range of 0.80±0.05 to 0.99±0.04 and 0.37±0.02 to 
0.56±0.04 g/cm3respectively. The non-aggregated nature of 
prepared MS is showed by excellent flowability expressed in 
terms of angle of repose less than 40 ° (table 2). 
 
Table 2: Results of micromeretics properties of ethyl cellulose microspheres (n=3) (average±SD) 
Batch code Mean particle size Bulk density Tapped density Angle of repose 
E1 187.12±7.2 0.90±0.05 0.48±0.01 29.6±5.2 ° 
E2 200.01±6.1 0.92±0.03 0.52±0.09  31.2±6.6 ° 
E3 234.21±10.2 0.99±0.04 0.56±0.04  33.9±4.4 ° 
E4 243.41±9.1 0.91±0.06 0.46±0.03 32.2±4.8 ° 
E5 188.17±4.6 0.90±0.02 0.47±0.02 29.4±8.7 ° 
E6 185.29±9.0 0.84±0.01 0.42±0.02 27.2±7.9 ° 
E7 174.41±11.4 0.80±0.05 0.37±0.02 26.4±0.1 ° 
E8 235.32±5.1 0.95±0.04 0.53±0.14  31.5±8.4 ° 
E9 240.42±3.9 0.96±0.05 0.54±0.21 32.2±4.7 ° 
 
Morphology  
The SEM photograph shows that the prepared MS were spherical in 
shape with a smooth and dense outer surface (fig. 2). The ruptured 
surface showing hollow nature of MS in the interior which makes 
them to float on the GIT fluid. During processing, it was found that 
when the stirring speed was kept at 600 rpm, the shapes of particles 
were found to be irregular for all formulations because the stirring 
speed was not fast enough to disperse the inner phase in outer 
phase and a huge coalesced mass was obtained. This is due in part to 
inadequate agitation of the media to disperse the inner phase in 
discrete droplets within the bulk phase. At stirring speed 1200 rpm, 
the turbulence caused frothing and adhesion of the microspheres to 
the container walls and propeller blade surfaces, resulting in high 
shear and a smaller size of the dispersed droplets. When stirring 
speed was set to 900 rpm the best spherical particles with good 
surface characteristics were obtained. 
 
 
Fig. 2: SEM images: A) Spherical shaped microsphere and B) 
Ruptured surface showing hollow nature of microspheres 
Buoyancy, yield and entrapment efficiency  
Flowability was observed by calculating percent buoyancy and was 
found that more than 71.8% MS remained floating at the end of 12 h. 
Percent buoyancy decreases with increase in the concentration of EC 
which may be due to increase in density of particle and decrease in 
porosity. Percent yield was greater than 68.4% for all the formulations, 
and it increases with increasing EC ratio. On increasing stirring speed 
from 600 to 900 rpm % yield increases (72.4-76.1%), whereas on 
further increase in speed of rotation to 1200 rpm it decreases. Fig. 3, 4 
shows the effect of stirring rate and concentration of emulsifier on 
various parameters studied. No significant effect of increasing emulsifier 
concentration on % yield was observed. On increasing the concentration 
of drug (10-30 mg) slight increase in yield was observed (76.1-80.4%).  
 
 
Fig. 3: Effect of stirring rate on various optimisation 
parameters. All data are represented as mean±SD (n=3) 
Sharma et al. 
Int J App Pharm, Vol 9, Issue 1, 2017, 44-49 
47 
The drug entrapment efficiency was found good for all the formulation 
(58.6-75.4%). The high entrapment of RG was found to be due to its 
poor water solubility. The extent of loading influenced the particle size 
distribution of microspheres. The proportion of larger particles was 
formed when loading was high. Increasing polymer concentration 
shows increase in drug loading (63.2-75.4%) [13]. The increase in 
stirring speed from 600 to 900 rpm increases entrapment, which 
decreases as stirring speed increased to 1200 rpm, which is due to 
reduced size of microspheres formed at a higher speed of rotation. The 
results were in accordance with an earlier report [19]. 
 
 
Fig. 4: Effect of emulsifier concentration on various optimization 
parameters. All data are represented as mean±SD (n=3) 
 
In vitro drug release and kinetics 
On the basis of good results of buoyancy, drug content, size and yield E2 
was selected as optimized formulation and thus its release was 
evaluated in pH 1.2. Release of drug shows no burst effect, hence 
showing homogenous drug distribution. The results were in agreement 
with earlier report [20]. Since EC is hydrophobic and insoluble in gastric 
fluid release of drug is not very high, only 65.1% drug was released from 
optimized formulation after 12 h. Thus, use of some hydrophilic polymer 
in combination with EC can enhance further release of drug. 
The data obtained for in vitro release was fitted into equations for 
the zero order, first order, Higuchi and Peppas model. The data were 
interpreted on the bases of regression coefficients obtained. In vitro 
release data follows first order kinetics (fig. 5) followed by Peppas 
and Higuchi model. Peppas equation has been applied to explain the 
release mechanism. The value of slope (n) was calculated and is 
≤0.89, showing coupling of diffusion and erosion mechanism called 
anomalous diffusion, indicating that drug release is controlled by 
more than one process. From these results, it can be concluded that 
release of drug follows first order, diffusion and erosion mechanism. 
 
 
Fig. 5: First order plot of optimized formulation 
 
Antidiabetic activity 
Biological studies were performed on healthy albino rats 
categorised in different groups. To study the antidiabetic effect of 
selected formulation alloxan induced diabetic rats were utilised. 
When repaglinide solution (pure) was given orally, the blood 
glucose level starts to decrease within 30 min. At150 min, blood 
glucose level reached to its minimum level, but after that, the level 
again starts to increase. The rapid decrease of a glucose level of pure 
repaglinide is due to the higher dissolution rate of a pure form of the 
drug in gastric fluid of the rat. The further increase in glucose level is 
due to the elimination of drug as it has a short biological half-life of 1 
h. Whereas formulations E2 shows a reduction in glucose level 
slower as compared to the pure drug during the initial hours which 
increases after 3rd h till the end of the study. Glucose level of the 
formulation started to decrease significantly after 1 h and this 
decrease continued up to the eighth h indicating controlled release 
of drug from the formulations. 
The decrease in glucose level of formulation even after 150 min as 
compared to a pure drug which shows an increase in glucose level 
reveals that the drug is released from the prepared formulation 
through EC polymer slowly in a controlled manner and thereby 
showing its pharmacological effect for longer time.  
 
 
Fig. 6: Blood glucose level of various groups of animals at different 
time interval. All data are represented as mean±SD (n=3) 
 
Histopathological studies 
Hyperglycaemia is known to cause harmful effects on functioning of 
vital tissues and it seems to be necessary to evaluate effects of 
antidiabetic drugs by biochemical and histopathological studies [21]. 
Histopathological studies show no detrimental effect of RG and 
formulation on rats. Pathological examination shows that the cellular 
structure of the heart, kidney, liver and pancreas were normal after 
administration of the formulation, similar as that of the control group. 
Cardiac tissues of normal control rats show normal anatomical 
features with normal structure of cardiocytes whereas, pure drug 
treated caused slight cellular infiltration along with partial 
fragmentation of muscle fibers (fig. 7). Formulation treated histology 
shows less effect of infiltration only mild degree of inflammation near 
cardiocytes and cellular swelling with scar formation was observed. 
Image of a kidney from animals of control group shows normal renal 
anatomy with healthy glomeruli and appearance of compact tissue. 
Kidney of RG treated rat shows slight inflammation in the 
glomerular and tubular area which was slight and mild harmful 
effect with only few incidence of occurrence of inflammation in rats 
treated with formulation (fig. 8). 
Slide of liver in control group of animal shows distinct and normal 
hepatocytes with no sign of necrosis. Very mild dilation of blood 
vessels and slight inflammatory changes (fig. 9) was observed in the 
liver of RG treated rat whereas in animals treated with formulation 
demonstrated similar non-lethal effects on hepatic histo-
architecture. There was a mild degree of fat accumulation near 
hepatocytes with mild cellular swelling. Pancreas is the principal 
organ for the synthesis of insulin, from a type II antidiabetic drug, it 
is expected that no harmful effects should be observed over 
structure and function of the pancreas and other vital organs. 
Normal pancreatic histo-architecture islet with no abnormality (fig. 
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10) was seen in the slide of control rat. Such an effect is supported 
due to the non-apoptotic effect of repaglinide over islet cells [22]. 
Whereas drug treated rats shows a slight degeneration of serous 
acini, numbers of islet and islet cells, whereas less anomaly with 
mild cellular inflammation, was seen on pancreas of formulation 
treated rats. Thus it can be concluded that formulations exerted no 
harmful effect on histo-architecture and cellular morphology of vital 
organs of alloxanized animals. 
 
 
Fig. 7: Histological slides: (a) normal control, (b) RG treated and (c) formulation treated of Heart 
 
 
Fig. 8: Histological slides: (a) normal control, (b) RG treated and (c) formulation treated of Kidney 
 
 
Fig. 9: Histological slides: (a) normal control, (b) RG treated and (c) formulation treated of liver 
 
 
Fig. 10: Histological slides: (a) normal control, (b) RG treated and (c) formulation treated of pancreas 
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CONCLUSION 
Extensive work on the formulation, characterization, in vitro release, 
antidiabetic effect and histopathological performance was evaluated. 
The development of formulation and optimisation yields the desired 
microspheres with drug release for 12 h and advantage of floatability 
in gastric juice for a prolonged time. The in vivo results obtained after 
administration of microspheres to healthy rats were satisfactory. 
Control release of drug from optimised formulation was observed 
during antidiabetic activity. The concept of formulating floating 
microspheres of RG offers a suitable, practical approach to achieve a 
prolonged therapeutic effect by continuously releasing the medication 
over an extended period of time by prolonging the gastric residence 
time, thus improving the oral bioavailability of the drug. It would be 
faster and more economical to alter the properties of the existing drug 
than developing new drug entities beneficially, hence this formulation 
will be a boon to novel drug dosage form.  
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